Harrison SA - Search Results

1

Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitis.

Sanyal AJ, Anstee QM, Trauner M, Lawitz EJ, Abdelmalek MF, Ding D, Han L, Jia C, Huss RS, Chung C, Wong VW, Okanoue T, Romero-Gomez M, Muir AJ, Afdhal NH, Bosch J, Goodman Z, Harrison SA, Younossi ZM, Myers RP. Sanyal AJ, et al. Among authors: harrison sa. Hepatology. 2022 May;75(5):1235-1246. doi: 10.1002/hep.32204. Epub 2022 Feb 7. Hepatology. 2022. PMID: 34662449 Free PMC article. Clinical Trial.

2

Diabetic hepatosclerosis: diabetic microangiopathy of the liver.

Harrison SA, Brunt EM, Goodman ZD, Di Bisceglie AM. Harrison SA, et al. Arch Pathol Lab Med. 2006 Jan;130(1):27-32. doi: 10.5858/2006-130-27-DHDMOT. Arch Pathol Lab Med. 2006. PMID: 16390234 Free article.

3

Impact of obesity on treatment of chronic hepatitis C.

Charlton MR, Pockros PJ, Harrison SA. Charlton MR, et al. Among authors: harrison sa. Hepatology. 2006 Jun;43(6):1177-86. doi: 10.1002/hep.21239. Hepatology. 2006. PMID: 16729327 Review.

4

Diagnosis and therapy of nonalcoholic steatohepatitis.

Torres DM, Harrison SA. Torres DM, et al. Among authors: harrison sa. Gastroenterology. 2008 May;134(6):1682-98. doi: 10.1053/j.gastro.2008.02.077. Gastroenterology. 2008. PMID: 18471547 Review.

5

Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial.

Harrison SA, Fecht W, Brunt EM, Neuschwander-Tetri BA. Harrison SA, et al. Hepatology. 2009 Jan;49(1):80-6. doi: 10.1002/hep.22575. Hepatology. 2009. PMID: 19053049 Clinical Trial.

6

Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis.

Gastaldelli A, Harrison SA, Belfort-Aguilar R, Hardies LJ, Balas B, Schenker S, Cusi K. Gastaldelli A, et al. Among authors: harrison sa. Hepatology. 2009 Oct;50(4):1087-93. doi: 10.1002/hep.23116. Hepatology. 2009. PMID: 19670459 Clinical Trial.

7

Induction pegylated interferon alfa-2b in combination with ribavirin in patients with genotypes 1 and 4 chronic hepatitis C: a prospective, randomized, multicenter, open-label study.

Brady DE, Torres DM, An JW, Ward JA, Lawitz E, Harrison SA. Brady DE, et al. Among authors: harrison sa. Clin Gastroenterol Hepatol. 2010 Jan;8(1):66-71.e1. doi: 10.1016/j.cgh.2009.08.036. Epub 2009 Sep 10. Clin Gastroenterol Hepatol. 2010. PMID: 19747986 Clinical Trial.

8

Thiazolidinedione therapy for nonalcoholic steatohepatitis: go, stop, or proceed with caution?

Harrison SA. Harrison SA. Hepatology. 2010 Feb;51(2):366-9. doi: 10.1002/hep.23473. Hepatology. 2010. PMID: 20101743 No abstract available.

9

Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection.

Starley BQ, Calcagno CJ, Harrison SA. Starley BQ, et al. Among authors: harrison sa. Hepatology. 2010 May;51(5):1820-32. doi: 10.1002/hep.23594. Hepatology. 2010. PMID: 20432259 Review.

10

Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.

Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, Landt CL, Harrison SA. Williams CD, et al. Among authors: harrison sa. Gastroenterology. 2011 Jan;140(1):124-31. doi: 10.1053/j.gastro.2010.09.038. Epub 2010 Sep 19. Gastroenterology. 2011. PMID: 20858492

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

375 results

Search Page